Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 0.0 | 5.0 |
Min SIP Amount | ₹500 | ₹500 |
Expense Ratio | 2.31 | 1.72 |
NAV | ₹14.16 | ₹360.07 |
Fund Started | 13 Mar 2023 | 08 Mar 2000 |
Fund Size | ₹251.17 Cr | ₹10979.71 Cr |
Exit Load | - | - |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 21.25% | 25.12% |
3 Year | - | 17.09% |
5 Year | - | 30.11% |
1 Year
3 Year
5 Year
Equity | 99.50% | 93.04% |
Cash | -0.06% | 6.96% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Gillette India Ltd. | 4.96% |
Ipca Laboratories Ltd. | 4.52% |
Abbott India Ltd. | 4.24% |
Muthoot Finance Ltd. | 4.19% |
HDFC Asset Management Company Ltd. | 4.18% |
V-Guard Industries Ltd. | 4.18% |
Persistent Systems Ltd. | 4.15% |
Petronet LNG Ltd. | 4.11% |
Coromandel International Ltd. | 4.10% |
Sundram Fasteners Ltd. | 4.07% |
Name | Assets |
---|---|
Reliance Industries Ltd. | 9.51% |
Samvardhana Motherson International Ltd. | 8.26% |
JIO Financial Services Ltd. | 7.65% |
Adani Power Ltd. | 7.60% |
Grasim Industries Ltd. | 5.83% |
Life Insurance Corporation of India | 5.77% |
Larsen & Toubro Ltd. | 5.55% |
Aurobindo Pharma Ltd. | 5.37% |
Britannia Industries Ltd. | 4.31% |
ITC Ltd. | 3.96% |
Name | Dhaval Patel | Ankit A Pande |
Start Date | 08 Mar 2023 | 22 Aug 2023 |
Name
Start Date
Description | The Scheme seeks to generate income and long-term capital appreciation from a diversified portfolio of predominantly equity and equity-related instruments. | The scheme aims to generate capital appreciation by investing predominantly in equity shares with growth potential. The secondary objective is to give dividend and other income. |
Launch Date | 13 Mar 2023 | 08 Mar 2000 |
Description
Launch Date